Synergistic Effects of BAY 60‐4552 and Vardenafil on Relaxation of Corpus Cavernosum Tissue of Patients with Erectile Dysfunction and Clinical Phosphodiesterase Type 5 Inhibitor Failure-Reference-Cited by-同舟云学术

Synergistic Effects of BAY 60‐4552 and Vardenafil on Relaxation of Corpus Cavernosum Tissue of Patients with Erectile Dysfunction and Clinical Phosphodiesterase Type 5 Inhibitor Failure

Published:2013-05 Issue:5 Volume:10 Page:1268-1277
ISSN:1743-6095
Container-title:The Journal of Sexual Medicine
language:en
Short-container-title:The Journal of Sexual Medicine

Author:

Albersen Maarten,Linsen Loes,Tinel Hanna,Sandner Peter,Van Renterghem Koenraad

Publisher

Elsevier BV

Subject

Urology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health

Reference24 articles.

1. Erectile dysfunction;Lue;N Engl J Med,2000

2. Improved penile histology by phalloidin stain: Circular and longitudinal cavernous smooth muscles, dual‐endothelium arteries, and erectile dysfunction‐associated changes;Lin;Urology,2011

3. A nitric oxide‐like factor mediates nonadrenergic‐noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle;Kim;J Clin Invest,1991

4. The future is today: Emerging drugs for the treatment of erectile dysfunction;Albersen;Expert Opin Emerg Drugs,2010

5. Sildenafil: An orally active type 5 cyclic GMP‐specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction;Boolell;Int J Impot Res,1996

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Etiology of Male Infertility: an Update;Reproductive Sciences;2023-11-30

2. Tadalafil-Loaded Self-Nanoemulsifying Chewable Tablets for Improved Bioavailability: Design, In Vitro, and In Vivo Testing;Pharmaceutics;2022-09-12

3. Novel Emerging Therapies for Erectile Dysfunction;The World Journal of Men's Health;2021

4. Nitric Oxide-cGMP Signaling in Hypertension;Hypertension;2020-10

5. Cavernous smooth muscles: innovative potential therapies are promising for an unrevealed clinical diagnosis;International Urology and Nephrology;2019-10-15